Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

Share Price is delayed by 15 minutes
Get Live Data
1,028.00    14.00 (1.38%)
Bid:
1,030.00
Ask:
1,031.00
Spread: 1.00 (0.097%)
Market Cap: £5.03b
BAB Live PriceLast checked at - London Stock Exchange

Intraday Babcock Share Chart

Babcock appoints new Chief Executive

1 Jul 2020 07:00

RNS Number : 6187R
Babcock International Group PLC
01 July 2020
 

1 July 2020

Babcock appoints new Chief Executive 

 

Babcock International Group PLC (Babcock), the aerospace and defence company, announces the appointment of David Lockwood as CEO, succeeding Archie Bethel, who earlier this year announced his intention to retire. David will join the Company and the Board on 17 August 2020 as CEO designate and will become CEO on 14 September 2020, at which point Archie will step down from the Board.

David was previously CEO of Cobham plc, one of the UK's largest defence companies and a leading global technology and services innovator. Prior to that, he was CEO of Laird PLC, a FTSE 250 technology company, from 2012 to 2016.

His career includes senior management roles at BT Global Services, BAE Systems and Thales Corporation. David has a Degree in Mathematics from the University of York and is a chartered accountant. He is a Fellow of the Royal Aeronautical Society and the Royal Society of Arts and Commerce. He received an OBE for services to industry in Scotland in 2011.

Ruth Cairnie, Chair, said:

"After an extensive search and selection process, I am delighted to welcome David to the Company. He brings wide-ranging knowledge of the defence and aviation markets, as well as a wealth of experience in both technology and innovation. His skills and industry expertise will help ensure the delivery of our operational performance and strategic objectives.

"I would like to thank Archie for his outstanding contribution to Babcock over 16 years. He enhanced our deep relationship with our customers, reflected in our record order book and pipeline, and made significant progress in internationalising the Company and streamlining our portfolio. We have been very fortunate to have a leader with such profound knowledge of the business. Archie will retire from the Board with our very best wishes and our sincere appreciation for everything he has achieved."

Archie Bethel said:

"It has been an honour and a privilege to serve at Babcock, which makes a unique contribution to national security and to saving lives. I would like to thank all our employees worldwide for their hard work and commitment over my time of service, which has been exemplified in their outstanding response to the pandemic."

David Lockwood said:

"I am looking forward to joining Babcock, a company I have long respected, which makes such an important contribution to the critical markets it serves. This is an exciting opportunity to position Babcock for further success and future growth, and to make full use of technology and innovation to support customers in the UK and internationally."

ends

 

 

 

 

For further information please contact:

 

Babcock International Group PLC

Simon McGough Kate Hill

Director of Investor Relations Group Director of Communications

Tel: +44 (0)7850 978 741 Tel: +44 (0)20 7355 5312

FTI Consulting

Nick Hasell, Alex Le May

Tel: +44 (0)20 3727 1340

 

Notes:

 

Babcock will make available the details relating to Archie Bethel required by section 430(2B) of the Companies Act 2006 in September. As Archie is retiring, he will be a good leaver in respect of Babcock's incentive schemes. The final arrangements will be in line with Babcock's remuneration policy.

 

Babcock will include the details of David's remuneration arrangements in the 2021 Remuneration Report but the key elements are as follows:

 

· Base salary of £800,000 per annum;

· Pension allowance of 10% of salary;

· Benefits in line with Babcock's remuneration policy;

· Eligible to participate in the Directors' annual bonus scheme up to 150% of salary (40% of which will be deferred for three years under Babcock's deferred bonus scheme) and Babcock's long term incentive plan up to an annual award of 200% of salary in respect of performance shares.

 

Babcock is not required to buy out any pre-existing arrangements.

 

In relation to Listing Rule 9.6.13R(1), David has no current directorships of publicly quoted companies and no such directorships in the previous five years other than those referred to above. In relation to Listing Rule 9.6.13R(2)-(6), there are no details to disclose in relation to David.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOABCGDLDDXDGGG
Date   Source Headline
21st Oct 20164:11 pmRNSHolding(s) in Company
17th Oct 20167:00 amRNSCapital Markets Day site visit
13th Oct 20161:14 pmRNSContract Award
4th Oct 201612:46 pmRNSPublication of Final Terms
23rd Sep 20164:45 pmRNSHolding(s) in Company
20th Sep 201611:37 amRNSPublication of a Prospectus
16th Sep 201612:39 pmRNSHolding(s) in Company
8th Sep 20169:00 amRNSContract Award
16th Aug 20164:44 pmRNSDirector/PDMR Shareholding
29th Jul 20164:30 pmRNSDirector/PDMR Shareholding
21st Jul 20164:32 pmRNSResult of AGM
21st Jul 20167:00 amRNSAnnual General Meeting Trading Update
20th Jul 20163:45 pmRNSHolding(s) in Company
8th Jul 20169:31 amRNSHolding(s) in Company
28th Jun 20169:13 amRNSDirector/PDMR Shareholding
22nd Jun 20169:15 amRNSDirector/PDMR Shareholding
20th Jun 20163:17 pmRNSDirector/PDMR Shareholding
17th Jun 201610:22 amRNSDirector/PDMR Shareholding
16th Jun 20163:44 pmRNSDirector/PDMR Shareholding
16th Jun 20169:14 amRNSAnnual Report and AGM Documents
14th Jun 20163:50 pmRNSDirector/PDMR Shareholding
3rd Jun 20161:56 pmRNSTotal Voting Rights
31st May 20163:29 pmRNSAdditional Listing
25th May 20167:00 amRNSFinal Results
20th May 20168:00 amRNSContract Announcement
18th May 20164:10 pmRNSHolding(s) in Company
12th May 20162:05 pmRNSDirector/PDMR Shareholding
12th May 20162:04 pmRNSDirector/PDMR Shareholding
13th Apr 20164:32 pmRNSDirector/PDMR Shareholding
13th Apr 20164:29 pmRNSDirector/PDMR Shareholding
14th Mar 20162:14 pmRNSDirector/PDMR Shareholding
14th Mar 201610:37 amRNSHolding(s) in Company
29th Feb 201610:02 amRNSHolding(s) in Company
17th Feb 201610:00 amRNSPhoenix II contract award
16th Feb 201610:24 amRNSAdoption of Financial Reporting Standard (FRS) 101
12th Feb 20163:24 pmRNSDirector/PDMR Shareholding
8th Feb 20164:20 pmRNSDirector/PDMR Shareholding
5th Feb 201611:01 amRNSDirector/PDMR Shareholding
3rd Feb 20161:33 pmRNSDirector/PDMR Shareholding
2nd Feb 201611:05 amRNSAscent joint venture contract award
28th Jan 20167:00 amRNSCEO succession
18th Jan 20163:15 pmRNSDirector/PDMR Shareholding
15th Jan 20164:54 pmRNSDirector/PDMR Shareholding
14th Dec 201511:32 amRNSDirector/PDMR Shareholding
11th Dec 201510:02 amRNSS430 (2B) Companies Act 2006
10th Dec 201510:46 amRNSDirectorate Change
1st Dec 20151:38 pmRNSDirector/PDMR Shareholding
26th Nov 201510:14 amRNSHolding(s) in Company
24th Nov 20153:00 pmRNSHolding(s) in Company
24th Nov 20157:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.